Search Results 841-850 of 16346 for pharmacogenetics
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Early detection of recurrent prostate cancer is crucial for patients beating the disease a second time. The work of a team of Mayo Clinic physicians and ...
This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...
The primary objectives for this study are to compare each investigational arm versus standard of care (SOC) for superiority in overall survival in 1st and/or ...
Latest stories · Preeclampsia linked to increased markers of brain cell damage, inflammation featured image · Expert Alert: Options for laryngeal regeneration ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...
About this study. The aim is the characterization of the microbiome of subjects experiencing benign reproductive tract disorders and its comparison to the ...
About this study. The purpose of this registry is to develop a database of patient experience that can be used for internal research, education, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.